Xencor Presents Data on XmAb5871 Program at American College of Rheumatology (ACR) 2015 Annual Meeting Investigational New Drug (IND) application filing for XmAb5871 in IgG4-Related Disease expected before year's end

⋮

0

← $

..going to article 71

X Mark channel Not-Safe-For-Work? cancel confirm NSFW Votes: (0 votes)

X Are you the publisher? Claim or contact us about this channel.

X No ratings yet.

X Search